The previous wording of the UK licence was use in long term maintenance treatment where a neuroleptic is required, e.g. schizophrenia, other psychoses (especially paranoid) and other mental or behavioural problems where maintenance treatment is clearly indicated.
The manufacturers have clarified this change in a recent communication to healthcare professionals